In the last trading session, 1.05 million Calidi Biotherapeutics Inc (AMEX:CLDI) shares changed hands as the company’s beta touched 1.05. With the company’s per share price at $0.97 changed hands at -$0.08 or -7.52% during last session, the market valuation stood at $25.16M. CLDI’s last price was a discount, traded about -1631.96% off its 52-week high of $16.80. The share price had its 52-week low at $0.58, which suggests the last value was 40.21% up since then.

Calidi Biotherapeutics Inc (AMEX:CLDI) trade information

Instantly CLDI was in red as seen at the end of in last trading. With action -28.60%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -15.57%, with the 5-day performance at -28.60% in the red. However, in the 30-day time frame, Calidi Biotherapeutics Inc (AMEX:CLDI) is 27.60% up.

The consensus price target for the stock as assigned by Wall Street analysts is 5.5, meaning bulls need an upside of 82.36% from its current market value. According to analyst projections, CLDI’s forecast low is 2 with 9 as the target high. To hit the forecast high, the stock’s price needs a -827.84% plunge from its current level, while the stock would need to soar -106.19% for it to hit the projected low.

According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.

The 2025 estimates are for Calidi Biotherapeutics Inc earnings to increase by 78.64%, but the outlook for the next 5-year period is at 69.01% per year.

CLDI Dividends

Calidi Biotherapeutics Inc is expected to release its next quarterly earnings report in March.

CPR INVESTMENTS INC. holds the second largest percentage of outstanding shares, with 1.0511% or 0.56 million shares worth $0.11 million as of 2024-06-30.